Spotlight Innovation Inc (STLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Spotlight Innovation Inc (STLT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH505100D
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company's product pipeline includes drug candidates for the treatment of cancer derived from specialized receptor binding proteins found in snake venom. It also develops therapeutics for the treatment of pain management derived from rattlesnake and cobra venom. Spotlight Innovation develops and commercializes drug candidates for the treatment of Zika Virus and spinal muscular atrophy. The company works in partnership with academic institutions and scientists. It operates through its subsidiaries to develop drugs. Spotlight Innovation is headquartered in Urbandale, Iowa, the US.

Spotlight Innovation Inc (STLT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Spotlight Innovation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Spotlight Innovation Raises USD 0.4 Million In Venture Financing 12

Partnerships 13

Spotlight Innovation Enters into Research Agreement with Indiana University 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

Spotlight Innovation Enters into Sponsored Research Agreement with Florida State University 15

Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16

Spotlight Innovation Enters into Research Agreement with Emory University 17

Licensing Agreements 18

Spotlight Innovation Enters into Licensing Agreement with Florida State University 18

Spotlight Innovation Enters into Licensing Agreement with Florida State University Research Foundation 19

Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 20

Caretta Therapeutics Enters into Licensing Agreement for Analgesic Products 21

Celtic Biotech Enters into Licensing Agreement with Instituto Butantan 22

Celtic Biotech Enters into Licensing Agreement for Chronic Kidney Disease 23

Equity Offering 24

Spotlight Innovation Raises USD0.5 Million in Private Placement of Shares and Warrants 24

Debt Offering 25

Spotlight Innovation Raises USD0.4 Million in Convertible Note Offering 25

Spotlight Innovation Raises USD0.8 Million in Private Placement of 6% Notes 26

Spotlight Innovation Raises USD1.4 Million in Private Placement 27

Acquisition 28

Spotlight Innovation Acquires Memcine Pharma 28

Spotlight Innovation Inc-Key Competitors 29

Spotlight Innovation Inc-Key Employees 30

Spotlight Innovation Inc-Locations And Subsidiaries 31

Head Office 31

Other Locations & Subsidiaries 31

Recent Developments 32

Corporate Communications 32

May 30, 2017: Spotlight Innovation Appoints Dr. June Beetler to Board of Directors 32

May 23, 2017: Spotlight Innovation Appoints John Krohn Interim Chief Executive Officer 33

Jan 10, 2017: Spotlight Innovation Appoints John Krohn President and Chief Operating Officer 34

Product News 35

Aug 07, 2017: New Chronic Pain Relief Product "Venodol" Now Available for Pre-order at Venodol.com 35

Jul 11, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Engages Public Relations Firm TransMedia Group 36

May 31, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Begins the Manufacturing Process for Venodol, a New Over-the-Counter Product to Treat Chronic Pain 37

Jan 18, 2017: Spotlight Innovation Subsidiary Caretta Therapeutics Announces Venodol, a New Over-the-counter Product to Treat Chronic Pain 38

Clinical Trials 39

Jul 24, 2018: Spotlight Innovation spinal muscular atrophy research collaborator professor Kevin Hodgetts receives USD 300,000 grant from Cure SMA 39

Feb 08, 2017: Spotlight Innovation Engages Top-Tier Contract Research Organization to Conduct Preclinical Studies of STL-182 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Spotlight Innovation Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Spotlight Innovation Inc, Deals By Therapy Area, 2012 to YTD 2018 9

Spotlight Innovation Inc, Medical Devices Deals, 2012 to YTD 2018 10

Spotlight Innovation Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Spotlight Innovation Raises USD 0.4 Million In Venture Financing 12

Spotlight Innovation Enters into Research Agreement with Indiana University 13

Spotlight Innovation Enters into Research Agreement with Brigham and Women's Hospital 14

Spotlight Innovation Enters into Sponsored Research Agreement with Florida State University 15

Spotlight Innovation Enters into Research Agreement with University of Alabama at Birmingham 16

Spotlight Innovation Enters into Research Agreement with Emory University 17

Spotlight Innovation Enters into Licensing Agreement with Florida State University 18

Spotlight Innovation Enters into Licensing Agreement with Florida State University Research Foundation 19

Spotlight Innovation Enters into Licensing Agreement with Indiana University Research & Technology 20

Caretta Therapeutics Enters into Licensing Agreement for Analgesic Products 21

Celtic Biotech Enters into Licensing Agreement with Instituto Butantan 22

Celtic Biotech Enters into Licensing Agreement for Chronic Kidney Disease 23

Spotlight Innovation Raises USD0.5 Million in Private Placement of Shares and Warrants 24

Spotlight Innovation Raises USD0.4 Million in Convertible Note Offering 25

Spotlight Innovation Raises USD0.8 Million in Private Placement of 6% Notes 26

Spotlight Innovation Raises USD1.4 Million in Private Placement 27

Spotlight Innovation Acquires Memcine Pharma 28

Spotlight Innovation Inc, Key Competitors 29

Spotlight Innovation Inc, Key Employees 30

Spotlight Innovation Inc, Subsidiaries 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Spotlight Innovation Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17500
Site License
USD 500 INR 35000
Corporate User License
USD 750 INR 52500

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com